Phreesia Q2 revenue up 46% to $51M; net loss widens to $24.4M; raises FY22 outlook

Phreesia, Inc.

2022-Q2 EPS reported -$0.73 revenue$99,298,000

Revenue $51.0M (+46% YoY); avg provider clients 1,987 (+19%); ARPU $19,720 (+14%).
Net loss $24.4M (diluted EPS -$0.48) vs $6.4M loss; Adj. EBITDA -$11.0M vs +$1.2M.
Cash $439.9M after $245.8M follow-on offering; FY22 revenue guidance raised to $195-198M.
Life sciences revenue $11.8M (nearly doubled); payment processing fees $16.3M (+38%).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.